Michael Ward, MD

Associate Professor (Clinical) and Director, Department of Pathology Residency Program, University of Utah School of Medicine

Specialties

• Bone and soft tissue pathology
• Cytopathology
• Resident and undergraduate medical education

Education

• Medical Degree—University of Texas Health Science Center at San Antonio
• Residency—Anatomic and Clinical Pathology, University of Utah/ARUP Laboratories
• Fellowship—Surgical Pathology, University of Utah/ARUP Laboratories
• Fellowship—Cytopathology, University of Utah/ARUP Laboratories

Research Interests

• Translocation associated soft tissue sarcomas
• PD-L1 expression in upper-tract urothelial carcinomas

Recent Publications

• Brown JM, Patel R, Smith-Fry K, et al. Genetically engineered mouse model of pleomorphic liposarcoma: immunophenotyping and histologic characterization. Neoplasia. 2024;48:100956.
• Wad M, Chadwick B, Abraham D. Dropper method for cytology slide staining: an effective and sustainable approach to eliminating cross contamination. Diagn Cytopathol. 2023;51(10):636-638.
• Sant T, Ward M, Shah LM, et al. Extrarenal malignant rhabdoid tumor infiltrating the brachial plexus and spinal canal. Neuroradiol J. 2023;36(1):104-107.
• Ward M, Albertson D, Furtado LV, et al. PD-L1 tumor cell expression in upper tract urothelial carcinomas is associated with higher pathologic stage. Appl Immunohistochem Mol Morphol. 2022;30(1):56-61.
• Li J, Mulvihill TS, Li L, et al. A role for SMARCB1 in synovial sarcomagenesis reveals that SS18-SSX induces canonical BAF destruction. Cancer Discov.  2021;11(10):2620-2637.